Skip to content

Modulation of Brain Blood Flow Using Dichoptic Visual and Auditory Stimulation

Modulation of Brain Blood Flow Using Dichoptic Visual and Auditory Stimulation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03632564
Enrollment
10
Registered
2018-08-15
Start date
2018-10-10
Completion date
2019-08-15
Last updated
2018-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Arterial Diseases

Brief summary

Modulation of brain blood flow using dichoptic Visual and Auditory stimulation using REVIVIEW system will be evaluated.

Detailed description

The participant will undergo baseline MRI to measure blood flow in the brain for comparison later on. After baseline MRI, the participant will observe stimulation using the REVIVIEW system for 20 minutes. The content the participants will see is a nature documentary, after which the participant will undergo additional MRI imaging to assess the change in blood flow in the brain.

Interventions

DEVICEREVIVIEW dichoptic audio-visual stimulation

REVIVIEW dichoptic audio-visual stimulation using video goggles

Sponsors

Visior Technologies Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- healthy subjects

Exclusion criteria

* History of brain diseases * Glasses * Diagnosed with Diabetes * Diagnosed with Degenerative brain diseases * Inability to undergo MRI

Design outcomes

Primary

MeasureTime frameDescription
Change in blood flow in the brain in respond to the stimulation1 hourEvaluate the change in blood flow in different parts of the brain, compared with baseline, after the cessation of stimulation, after 30 minutes and after 60 minutes.

Countries

Israel

Contacts

Primary ContactArie Orenstain, Prof.
Arie.Orenstain@sheba.health.gov.il972-3-5302993
Backup ContactYael Mardor, PhD
yael.mardor@sheba.health.gov.il972-3-5302993

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026